Pharmaceutical Sterility Testing Market Outlook (2023 to 2033)

The pharmaceutical sterility testing market is anticipated to be generated global sales revenue of US$ 1,250.7 million in 2023. Demand is expected to develop at a CAGR of 11.8% to reach a valuation of US$ 3,815.6 million by 2033.

Sterility testing applications are endless in the pharmaceutical, biotech, and medical device industries. The need for sterility testing in pharmaceuticals is greatly increasing since it covers the important stage of investigating the quality of raw materials, as well as process control and validation of finished products.

The pharmaceutical and biopharmaceutical production business experienced increasing demand for sterility testing. This is due to the severity and high infection rate of diseases, as well as the growing number of medications and vaccines. As a result, there is now a huge requirement for rigorous sterility of the items.

Rising drug launches and life sciences research and development prove to be driving factors for the industry. The demand for pharmaceutical sterility testing is also predicted to increase due to the rising need for sterilized goods internationally, as well as a few potential product safety concerns.

Attributes Details
Expected Market CAGR (2023 to 2033) 11.8%
Expected Market Size (2023) US$ 1,250.7 million
Expected Market Size (2033) US$ 3,815.6 million

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Pharmaceutical Sterility Testing Adoption Analysis (2018 to 2022) vs Market Outlook (2023 to 2033)

The background of the market is quite promising, and numbers are likely to increase during the research period. A number of developing nations have sped up the launch of new medicines in order to meet the world's rising need for healthcare. By doing this, the scope for CAGR increases from 9.8% (2018 to 2022) to 11.8% by 2033. As a result of the rising prevalence of chronic and infectious diseases, there is an increasing demand for pharmaceuticals on a global scale. For instance,

  • The WHO (World Health Organization) announced in February 2021 that cardiovascular diseases remain one of the leading causes of mortality worldwide, killing 17.9 million people a year.

Future illness load is anticipated to increase demand for pharmaceuticals, supporting the need for pharmaceutical sterility testing. Due to this, the global market had the potential to thrive. In 2018, the market was valued at US$ 773.7 million, and by 2022, it reached US$ 1,124.7 million.

The regulatory changes have significantly improved the likelihood of widespread adoption. Drugs like Elagolix and Lanadelumab, whose debut is considerably assisting the market's growth, are biopharmaceutical products that require special sterility testing. Given all of these influences, the market is probably anticipating a 1.1x growth between 2022 and 2023.

How Does Sterility Testing for Pharmaceutical Products Find Its Way to Market Profits?

  • The need for various types of sterility testing is driving the growth of the entire industry. These sterility testing types include sterility testing medical devices, b/f testing sterility, hypothesis testing, sgs sterility testing, VHP(Vaporized Hydrogen Peroxide) Ingress Testing, etc.,
  • High levels of consolidation, strict regulatory environments, and drawn-out licensing procedures all pose serious obstacles for new market entrants. However, this can be resolved as many businesses enter the kit testing market, which offers a consistent flow of client revenue.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Comparative View of the Adjacent Market

Pharmaceutical Sterility Testing Market:

Attributes Pharmaceutical Sterility Testing Market
CAGR (2023 to 2033) 11.8%
Market Value (2033) US$ 3,815.6 million
Growth Factor Increasing prevalence of infectious disease
Opportunity Favorable regulatory changes
Trends Rising research and development in life sciences

Cystatin C Testing Market:

Attributes Cystatin C Testing Market
CAGR (2023 to 2033) 7.5%
Market Value (2033) US$ 372.47 million
Growth Factor Rising number of research labs, hospitals, and diagnostic centers
Opportunity Increased government investment in the market
Trends Rising disposable income with health awareness

Pharmaceutical Dissolution Testing Market:

Attributes Pharmaceutical Dissolution Testing Market
CAGR (2023 to 2033) 8.3%
Market Value (2033) US$ 1,538.48 million
Growth Factor Improvement in healthcare systems
Opportunity Profitable developments in the in-vitro testing dissolution assays
Trends Increasing efforts and awareness about healthcare products

Regional Analysis

In 2022, it is anticipated that North America accounted for 39% of the global pharmaceutical sterility testing market. The existence of numerous international and domestic competitors in the area is responsible for the region's rise.

During the forecast period, a huge amount of money is likely to be spent on research and development to support the growth of North America market. The biopharmaceutical business has a substantial total economic impact on the economy of America.

What Benefits the Key Players in the United States Market?

The United States held a dominant market share of 41.5% in 2022. This is due to the factors such as:

  • Presence of numerous international pharmaceutical and biopharmaceutical businesses.
  • Significant financing from both the public and commercial sectors in the nation.

For instance, PreHevbrio was introduced by VBI Vaccines Inc. in March 2022 for the treatment of persons aged 18 years old. It is for those who are at risk of contracting any of the recognized subtypes of the hepatitis B virus (HBV). In November 2021, the FDA authorized this vaccine as the exclusive adult 3-antigen HBV vaccine. Consequently, Canada spent US$ 23,400 million internally on pharmaceutical research and development in 2021, and it reached US$ 23,800 million in 2022, a 1.7% increase.

Pharmaceutical Sterility Testing in China Market Focus on Compiling with the Standards

By 2033, China is anticipated to hold a significant rank in the pharmaceutical sterility testing sector, with a CAGR of 12.1%. This is a result of emerging countries increasingly harmonizing their regulatory norms with ICH standards. Additionally, the region's emerging economies are taking a variety of steps to expand their domestic pharmaceutical market and are enticing multinational corporations to establish operations there.

Contract research organizations (CROs) are anticipated to expand significantly over the next few years. Sterile testing services are significantly being outsourced to CROs because of the benefits they provide including flexibility, cost-effectiveness, and access to specialist knowledge. The primary end-users of sterility testing services in the nation are anticipated to be the biopharmaceutical industry and CROs.

Research and Development Creates a Sizable Market in India

India is prepared to manufacture medical devices and conduct extensive sterility testing due to substantial pharmaceutical investment. By 2033, India is projected to have a 12.8% CAGR.

According to the Union Budget for the years 2021 to 2022, the Indian Ministry of Science and Technology allocated US$ 430 million, a 25% increase from the budget for the years 2020 to 2021, for the DBT (Department of Biotechnology). This is primarily for biotechnology research and development, as well as industrial and entrepreneurship development in the nation. This budget sets new goals for India pharmaceutical sterility testing market. In accordance with the analysis, the Indian biotechnology market was estimated to be worth US$ 70,200 million in 2020; by 2025, it is anticipated to be worth US$ 150,000 million.

Automated Techniques Lead the Market in Germany

In Germany, automated methods rule the market. The market was initially growing, with a share of 6.2% in 2022, and by 2033, it is projected to have a wide scope. Automated systems that contribute effectively to the global industry include the BacT/ALERT system. These techniques are made to be highly sensitive and specific in identifying the presence of microorganisms in pharmaceutical items.

Germany has a stringent regulatory framework that is overseen by the European Pharmacopoeia (Ph. Eur.) and the German Medicines Act (AMG). All pharmaceutical products that are intended for infusion, implantation, or injection into the human body must pass sterility testing. This testing is essential to make sure the product is devoid of living microorganisms like bacteria, viruses, and fungi that possibly infect people or create other adverse effects.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category Analysis

Category Product Type
Top-segment Kits & Reagents
Market Share (2022) 39.7%
Category Services
Top-segment Outsourced
Market Share (2022) 54.1%
Category Test type
Top-segment Bacterial endotoxin testing
Market Share (2022) 38.4%

Which Services are Popular in the Pharmaceutical Sterility Testing Industry?

  • By accounting for 54.1% of the market in 2022, the outsourcing segment had the top share.
  • Small and medium-sized manufacturers of pharmaceuticals and medical devices do not always have the resources to undertake reliable sterility testing. Thus, they are likely to rather outsource these services to meet FDA standards.
  • Outsourcing helps pharmaceutical and medical device companies save time and money, as they don't have to find and train new employees or buy new equipment.
  • Pharmaceutical sterility testing services are gradually being outsourced by large pharmaceutical companies as they attempt to concentrate on their core capabilities, such as marketing. These elements have had a key role in the segment's growth.

Kits and Reagents: Top Segment based on Product Type

Through 2033, the kits and reagents market is predicted to experience significant growth. The availability of a variety of items that aid in reducing the danger of false negative and false positive results is credited with this increase. These also consist of sterility testing pumps, which are easily integrated into any testing environment, streamline workflow, and help to maximize safety.

Over the anticipated period, segmental growth is expected to be boosted by the rising demand for comparable products.

Which Testing Type Gives Accurate Results?

In 2022, the segment for bacterial endotoxin testing held the leading market share with 38.4%. These tests are used to evaluate medical equipment like implants. The market for this category is expanding as a result of rising parenteral medication and implant demand. Along with an increase in the number of drug and medical device launches, there is a growing emphasis on product quality.

Competitive Landscape

How do Pharmaceutical Sterility Testing Manufacturers Expand in the Market?

The demand for pharmaceutical sterility testing is projected to increase along with medical improvements, and producers can profit from these technological developments.
The growth of the biotechnology sector offers businesses a lot of room for future advancements.

Concerns like the safety of biological pharmaceuticals are surging. New technological advancements in the area of sterility testing have improved the procedure's efficiency, allowing manufacturers to introduce new products in the market.

Regulatory Scrutiny: Bane or Boon for Key Players in the Pharmaceutical Sterility Testing Market

The market is highly fragmented due to the presence of multiple local and MNC contract service providers and research facilities. The main strategies employed by the bulk of these organizations include regional growth and digitalization of service delivery for sterility testing. Companies in the sector are subject to intense regulatory scrutiny and must abide by rules relating to the security of pharmaceutical products. As a result, specialized consulting companies have emerged. These companies offer services related to pharmaceutical sterility testing that are related to regulatory compliance and quality assurance.

Recent Developments:

  • In June 2022, Lee, Massachusetts-based fill-finish CMO Berkshire Sterile Manufacturing (BSM) declared that its sterility testing isolator was prepared to conduct on-site sterility testing for its GMP batches. Most of the clients of the business, if not all of them, should see a short release due to the new service.
  • The establishment of a newly expanded center of excellence for microbiological laboratory testing and improved sterilizing capacity in Nelson Labs' and Sterigenics Deutschland GmbHs Wiesbaden, Germany, facilities were both announced for September 2021.
  • The EndoScan-V software platform for endotoxin testing and the Celsis automated detection system for assessing the fast sterility of pharmaceutical pharmaceuticals were both introduced by Charles River Laboratories in September 2019.

Key Players Operating in the Pharmaceutical Sterility Testing Market

  • Merck KGaA
  • bioMerieux SA
  • Thermo Fisher Scientific Inc.
  • Charles River Laboratories International Inc.
  • Others

Key Segments

By Product:

  • Kits and Reagents
  • Instruments

By Application:

  • Sterile Drugs
  • Biologics and Therapeutics
  • Medical Devices

By Test Type:

  • Sterility Testing
    • Membrane Filtration
    • Direct Inoculation
  • Bacterial Endotoxin Testing
  • Rapid Micro Test
  • Container Closure Integrity Testing
  • Electrical Resistance
  • Bioburden Testing
  • ATP Bioluminescence
  • Fluorescent Labeling
  • Others

By Services:

  • In-House
  • Outsourced

By End Use:

  • Compounding Pharmacies
  • Medical Devices Companies
  • Pharmaceutical Companies

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa (MEA)

Frequently Asked Questions

How Big is the Pharmaceutical Sterility Testing Market?

The market is valued at US$ 1,250.7 million in 2023.

Who are the Key Pharmaceutical Sterility Testing Market Players?

SGS SA, Toxikon, Inc., and Pace Analytical Services are key market players.

Which are the Key Asian Countries in the Pharmaceutical Sterility Testing Market?

India, Japan, and China dominate the Asian market.

How Big Will the Pharmaceutical Sterility Testing Market by 2033?

The market is estimated to reach US$ 3,815.6 million by 2033.

Which Region holds high Lucrativeness?

Asia-Pacific is projected to emerge as a lucrative market.

Table of Content

1. Executive Summary | Pharmaceutical Sterility Testing Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. Kits and Reagents

        5.3.2. Instruments

        5.3.3. Services

    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033

        6.3.1. Sterile Drugs

        6.3.2. Medical Devices

        6.3.3. Biologics

        6.3.4. Therapeutics

    6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Test Type, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Test Type, 2023 to 2033

        7.3.1. Sterility Testing

            7.3.1.1. Membrane Filtration

            7.3.1.2. Direct Inoculation

        7.3.2. Bioburden Testing

        7.3.3. Bacterial Endotoxin Testing

        7.3.4. Container Closure Integrity Testing

        7.3.5. Rapid Micro Test

            7.3.5.1. ATP Bioluminescence

            7.3.5.2. Fluorescent Labeling

            7.3.5.3. Electrical Resistance

        7.3.6. others

    7.4. Y-o-Y Growth Trend Analysis By Test Type, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Test Type, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Manufacturing

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Manufacturing, 2018 to 2022

    8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Manufacturing, 2023 to 2033

        8.3.1. In-House

        8.3.2. Outsourced

    8.4. Y-o-Y Growth Trend Analysis By Manufacturing, 2018 to 2022

    8.5. Absolute $ Opportunity Analysis By Manufacturing, 2023 to 2033

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use

    9.1. Introduction / Key Findings

    9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End Use, 2018 to 2022

    9.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End Use, 2023 to 2033

        9.3.1. Compounding Pharmacies

        9.3.2. Medical Devices Companies

        9.3.3. Pharmaceutical Companies

    9.4. Y-o-Y Growth Trend Analysis By End Use, 2018 to 2022

    9.5. Absolute $ Opportunity Analysis By End Use, 2023 to 2033

10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    10.1. Introduction

    10.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    10.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. Asia Pacific

        10.3.5. MEA

    10.4. Market Attractiveness Analysis By Region

11. North America Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. United States of America

            11.2.1.2. Canada

        11.2.2. By Product

        11.2.3. By Application

        11.2.4. By Test Type

        11.2.5. By Manufacturing

        11.2.6. By End Use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Application

        11.3.4. By Test Type

        11.3.5. By Manufacturing

        11.3.6. By End Use

    11.4. Key Takeaways

12. Latin America Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Brazil

            12.2.1.2. Mexico

            12.2.1.3. Rest of Latin America

        12.2.2. By Product

        12.2.3. By Application

        12.2.4. By Test Type

        12.2.5. By Manufacturing

        12.2.6. By End Use

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Application

        12.3.4. By Test Type

        12.3.5. By Manufacturing

        12.3.6. By End Use

    12.4. Key Takeaways

13. Europe Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. Germany

            13.2.1.2. United Kingdom

            13.2.1.3. France

            13.2.1.4. Spain

            13.2.1.5. Italy

            13.2.1.6. Rest of Europe

        13.2.2. By Product

        13.2.3. By Application

        13.2.4. By Test Type

        13.2.5. By Manufacturing

        13.2.6. By End Use

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Application

        13.3.4. By Test Type

        13.3.5. By Manufacturing

        13.3.6. By End Use

    13.4. Key Takeaways

14. Asia Pacific Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

            14.2.1.4. Singapore

            14.2.1.5. Thailand

            14.2.1.6. Indonesia

            14.2.1.7. Australia

            14.2.1.8. New Zealand

            14.2.1.9. Rest of Asia Pacific

        14.2.2. By Product

        14.2.3. By Application

        14.2.4. By Test Type

        14.2.5. By Manufacturing

        14.2.6. By End Use

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By Application

        14.3.4. By Test Type

        14.3.5. By Manufacturing

        14.3.6. By End Use

    14.4. Key Takeaways

15. MEA Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Product

        15.2.3. By Application

        15.2.4. By Test Type

        15.2.5. By Manufacturing

        15.2.6. By End Use

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product

        15.3.3. By Application

        15.3.4. By Test Type

        15.3.5. By Manufacturing

        15.3.6. By End Use

    15.4. Key Takeaways

16. Key Countries Global Market Analysis

    16.1. United States of America

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Product

            16.1.2.2. By Application

            16.1.2.3. By Test Type

            16.1.2.4. By Manufacturing

            16.1.2.5. By End Use

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Product

            16.2.2.2. By Application

            16.2.2.3. By Test Type

            16.2.2.4. By Manufacturing

            16.2.2.5. By End Use

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Product

            16.3.2.2. By Application

            16.3.2.3. By Test Type

            16.3.2.4. By Manufacturing

            16.3.2.5. By End Use

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Product

            16.4.2.2. By Application

            16.4.2.3. By Test Type

            16.4.2.4. By Manufacturing

            16.4.2.5. By End Use

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Product

            16.5.2.2. By Application

            16.5.2.3. By Test Type

            16.5.2.4. By Manufacturing

            16.5.2.5. By End Use

    16.6. United Kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Product

            16.6.2.2. By Application

            16.6.2.3. By Test Type

            16.6.2.4. By Manufacturing

            16.6.2.5. By End Use

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Product

            16.7.2.2. By Application

            16.7.2.3. By Test Type

            16.7.2.4. By Manufacturing

            16.7.2.5. By End Use

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Product

            16.8.2.2. By Application

            16.8.2.3. By Test Type

            16.8.2.4. By Manufacturing

            16.8.2.5. By End Use

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Product

            16.9.2.2. By Application

            16.9.2.3. By Test Type

            16.9.2.4. By Manufacturing

            16.9.2.5. By End Use

    16.10. China

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Product

            16.10.2.2. By Application

            16.10.2.3. By Test Type

            16.10.2.4. By Manufacturing

            16.10.2.5. By End Use

    16.11. Japan

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Product

            16.11.2.2. By Application

            16.11.2.3. By Test Type

            16.11.2.4. By Manufacturing

            16.11.2.5. By End Use

    16.12. South Korea

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Product

            16.12.2.2. By Application

            16.12.2.3. By Test Type

            16.12.2.4. By Manufacturing

            16.12.2.5. By End Use

    16.13. Singapore

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Product

            16.13.2.2. By Application

            16.13.2.3. By Test Type

            16.13.2.4. By Manufacturing

            16.13.2.5. By End Use

    16.14. Thailand

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Product

            16.14.2.2. By Application

            16.14.2.3. By Test Type

            16.14.2.4. By Manufacturing

            16.14.2.5. By End Use

    16.15. Indonesia

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Product

            16.15.2.2. By Application

            16.15.2.3. By Test Type

            16.15.2.4. By Manufacturing

            16.15.2.5. By End Use

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Product

            16.16.2.2. By Application

            16.16.2.3. By Test Type

            16.16.2.4. By Manufacturing

            16.16.2.5. By End Use

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Product

            16.17.2.2. By Application

            16.17.2.3. By Test Type

            16.17.2.4. By Manufacturing

            16.17.2.5. By End Use

    16.18. GCC Countries

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Product

            16.18.2.2. By Application

            16.18.2.3. By Test Type

            16.18.2.4. By Manufacturing

            16.18.2.5. By End Use

    16.19. South Africa

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Product

            16.19.2.2. By Application

            16.19.2.3. By Test Type

            16.19.2.4. By Manufacturing

            16.19.2.5. By End Use

    16.20. Israel

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Product

            16.20.2.2. By Application

            16.20.2.3. By Test Type

            16.20.2.4. By Manufacturing

            16.20.2.5. By End Use

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product

        17.3.3. By Application

        17.3.4. By Test Type

        17.3.5. By Manufacturing

        17.3.6. By End Use

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Pacific Bio labs

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

                18.1.1.5.2. Product Strategy

                18.1.1.5.3. Channel Strategy

        18.1.2. STERIS

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

                18.1.2.5.2. Product Strategy

                18.1.2.5.3. Channel Strategy

        18.1.3. Boston Analytical

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

                18.1.3.5.2. Product Strategy

                18.1.3.5.3. Channel Strategy

        18.1.4. Nelson Laboratories, LLC

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

                18.1.4.5.2. Product Strategy

                18.1.4.5.3. Channel Strategy

        18.1.5. Sartorius AG

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

                18.1.5.5.2. Product Strategy

                18.1.5.5.3. Channel Strategy

        18.1.6. SOLVIAS AG

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

                18.1.6.5.2. Product Strategy

                18.1.6.5.3. Channel Strategy

        18.1.7. SGS SA

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

                18.1.7.5.2. Product Strategy

                18.1.7.5.3. Channel Strategy

        18.1.8. Laboratory Corporation of America Holding

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

                18.1.8.5.2. Product Strategy

                18.1.8.5.3. Channel Strategy

        18.1.9. Pace Analytical

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

                18.1.9.5.2. Product Strategy

                18.1.9.5.3. Channel Strategy

        18.1.10. Charles River Laboratories

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

                18.1.10.5.2. Product Strategy

                18.1.10.5.3. Channel Strategy

        18.1.11. Thermo Fisher Scientific, Inc.

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

                18.1.11.5.2. Product Strategy

                18.1.11.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Pharmaceutical Dissolution Testing Services Market

December 2022

REP-GB-15959

270 pages

Healthcare

Cystatin C Testing Market

September 2024

REP-GB-10541

Upcoming

Explore Healthcare Insights

View Reports
Future Market Insights

Pharmaceutical Sterility Testing Market